Clinical Trials Insight: 700048347
Phase of Trial: Phase III
Latest Information Update: 19 Aug 2010
At a glance
- Drugs Dexpramipexole (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Registrational; Therapeutic Use
- Sponsors Biogen
- 19 Aug 2010 Biogen Idec is expected to initiate this trial in the first half of 2011, according to a media release.
- 19 Aug 2010 Biogen Idec and Knopp Neurosciences have entered into a worldwide agreement under which Biogen Idec will develop and commercialise dexpramipexole, according to a Biogen Idec media release.
- 03 Sep 2009 New trial record.